Aprecap

Aprecap 125/80 Product Image

Rs.1,200.00

Aprecap 125/80

(15 customer reviews)

Aprecap 125/80, developed by Glenmark, is a combination medication containing Aprepitant 125mg and Dexamethasone 80mg. It is primarily used in the prevention of nausea and vomiting associated with chemotherapy and surgery. This medication is highly effective in providing relief from acute and delayed chemotherapy-induced nausea and vomiting (CINV), as well as managing post-operative nausea.

Brand: Glenmark Composition: Aprepitant 125mg + Dexamethasone 80mg

Product Introduction

Aprecap 125/80 is an advanced combination antiemetic medication that plays a vital role in preventing nausea and vomiting caused by chemotherapy and surgical procedures. The active ingredients, Aprepitant and Dexamethasone, work synergistically to block the effects of substances in the body that trigger nausea and vomiting.

This medication is part of a comprehensive treatment protocol aimed at improving patient comfort and enhancing the effectiveness of cancer treatments and surgeries.

Uses of Aprecap 125/80

Aprecap 125/80 is primarily used for:

Aprecap 125/80 Uses
  • Prevention of Chemotherapy-Induced Nausea and Vomiting – Affects both acute and delayed nausea.
  • Post-Surgical Nausea Control – Reduces nausea after surgical procedures.
  • Improved Patient Comfort – Enhances overall patient well-being during treatment.

Aprecap 125/80 supports the management of nausea in patients undergoing chemotherapy or surgery, providing effective relief for improved quality of life.

Side Effects of Aprecap 125/80

Common side effects of Aprecap 125/80 may include:

  • Dizziness
  • Fatigue
  • Constipation
  • Headache
  • Loss of appetite

Less Common Side Effects

Less frequent but more serious side effects may include:

  • Liver dysfunction
  • Severe allergic reactions
  • Elevated blood sugar
  • Severe nausea or vomiting

We are pleased to offer you this product.

Aprecap 125/80 is a trusted medication for those undergoing chemotherapy or surgery, offering effective relief from nausea and vomiting with minimal side effects when used appropriately.

  • Take as prescribed by your healthcare provider, usually before chemotherapy or surgery.
  • Follow dosage instructions to ensure effectiveness.
  • Do not take more than the prescribed dose.

Aprecap 125/80 combines Aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist, with Dexamethasone, a corticosteroid. Together, they block the pathways responsible for triggering nausea and vomiting, providing relief for patients undergoing chemotherapy or surgery.

  • Effective in controlling chemotherapy-induced nausea and vomiting.
  • Convenient fixed-dose combination.
  • Reduces the need for additional antiemetic medications.
  • Well-tolerated in most patients.
  • Monitor liver function during treatment.
  • Be cautious if you have a history of high blood sugar or diabetes.
  • Inform your doctor of any allergic reactions to medications.

Aprecap 125/80 offers an excellent solution for patients facing nausea from chemotherapy or surgery. Always consult your healthcare provider for personalized recommendations and treatment.